Carles Calatayud received his degree in Biotechnology (2011) from the Polytechnic University of Valencia. During his last year of the degree, he worked in the Experimental Hepatology Unit at the Health Research Institute La Fe, Valencia, where, he investigated the effect of two hepatoendoderm-determining transcription factors in the somatic cell reprogramming to pluripotency. He joined the laboratory in 2012 as a Master student in Biomedical Research. Currently he is enrolled with the FPU fellowship in the PhD programme in Biomedicine, Neuroscience research area. His main focus is to study the genetic contribution of both the LRRK2 mutation and the genomic environment to the Parkinson’s disease pathogenesis.